Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 44

Sort by

Sort Order Select

Journal Articles

MYC and BCL2 mRNA Expression As Determined By NGS Predicts Survival in DLBCL in GCB but Not in ABC Subgroup

Blood (2019) 134 (Supplement_1): 5092.

https://doi.org/10.1182/blood-2019-128492

Published: 2019

Journal Articles

Cell of Origin and Treatment Impact on the Outcome of Monomorphic Post-Transplant Lymphoproliferative Disorder-Diffuse Large B-Cell Lymphoma Subtype

Francesca Montanari, MD, Changchun Deng, MD PhD, Ahmed Sawas, MD, Jennifer Kimberly Lue, MD, Enrica Marchi, MD, PhD, Dejan Radeski, MBBS, FRACP, FRCPA, Bin Cheng, PhD, Govind Bhagat, MD, Owen A. O'Connor, MD PhD

Blood (2019) 134 (Supplement_1): 2909.

https://doi.org/10.1182/blood-2019-131841

Published: 2019

Journal Articles

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Blood (2019) 134 (Supplement_1): 2891.

https://doi.org/10.1182/blood-2019-126927

Published: 2019

Journal Articles

Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma

Xiang Li, Rachel Kositsky, Anupama Reddy, PhD, Cassandra Love, Kikkeri Naresh, Jean L. Koff, MD, Ilja Nystrand, Sirpa Leppä, MD PhD, Annika Pasanen, MD PhD, Marja-Liisa Karjalainen-Lindsberg, MD PhD, Johannes Dunkel, Panu Kovanen, MD PhD, Qiu Qin, Govind Bhagat, MD, Rebecca J Leeman-Neill, MDPhD, Rashmi S. Goswami, MD PhD, Sarah Wildeman, Jan Delabie, MDPhD, Richard Burack, MD PhD, Andrew G Evans, MD PhD, Catalina Amador, MD, Ji Yuan, Hina Naushad Qureishi, Shaoying Li, MD, Jie Xu, C. Cameron Yin, MD PhD, Anne Ortved Gang, Peter H. Norgaard, MDPhD, Mette Ø Pedersen, MD, Jason Yongsheng Chan, MBBS, MRCP, Daryl Ming Zhe Cheah, Shin Yeu Ong, MD FRCPath, Chee Leong Cheng, FRCPA, FRCPath, MBBS, Lianne Lee, Felik Paulua, Sarah L. Ondrejka, DO, Eric D. Hsi, MD, Magdalena Czader, MD PhD, Lin Wang, PhD, Amber Landis, Michael C. Churnetski, David L. Jaye, MD, Christopher R. Flowers, MD MS, Chad M. McCall, MD PhD, Jadee Neff, MD PhD, Matthew S. McKinney, MD, Yuri Fedoriw, Eric Powers, Nathan D Montgomery, MD, Agata M. Bogusz, MDPhD, Andrea Stafford Hintz, HSLT, Alexandra E. Kovach, MD, Nishitha Reddy, MD, Mary Ann Thompson Arildsen, MD PhD, Emily F Mason, MD PhD, Ridas Juskevicius, MD, William Choi, MBBS,MRCP, Rex Au-Yeung, Eric Tse, MBBS, PhD FRCP, FRCPath, Vincent Sarno, Amy Chadburn, MD, Rafael Lopez, MD, Jennifer R Chapman, MD, Amir Behdad, MD, Neta Goldschmidt, MD, John Goodlad, MD, Cathy Burton, Raju Pillai, MD, Abner Louissaint, Jr., MD PhD, Dina Sameh Soliman, MD MB, MMSc, Razvan Panea, Tushar Dave, Barbara Xiong, Eileen Smith, Sandeep Dave, MD

Blood (2019) 134 (Supplement_1): 19.

https://doi.org/10.1182/blood-2019-130255

Published: 2019

Journal Articles

Novel Drugs and Clinical Trial-Based Treatments Prolong Survival of Peripheral T-Cell Lymphomas (PTCL) Patients: Single Institution Retrospective Analysis

Helen Ma, MD, Enrica Marchi, MD, PhD, Bin Cheng, PhD, Govind Bhagat, MD, Owen A. O'Connor, MD PhD

Blood (2019) 134 (Supplement_1): 3486.

https://doi.org/10.1182/blood-2019-123587

Published: 2019

Journal Articles

Higher Stability of Mutant mRNA As Compared to Wild-Type mRNA in Diffuse Large B-Cell Lymphoma

Blood (2019) 134 (Supplement_1): 1499.

https://doi.org/10.1182/blood-2019-128516

Published: 2019

Journal Articles

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Blood (2017) 130 (Supplement 1): 197.

https://doi.org/10.1182/blood.V130.Suppl_1.197.197

Published: 2017

Journal Articles

Molecular Characterization of Post-Transplant Plasmablastic Lymphomas Implicates RAS , TP53 , and NOTCH Mutations and MYC Deregulation in Disease Pathogenesis

Rebecca J Leeman-Neill, MDPhD, Patricia M. Raciti, MD, Susan J Hsiao, MD PhD, Murty Vundavalli, PhD, Bachir Alobeid, MD, Mahesh M Mansukhani, MD, Govind Bhagat, MD

Blood (2017) 130 (Supplement 1): 4014.

https://doi.org/10.1182/blood.V130.Suppl_1.4014.4014

Published: 2017

Journal Articles

Activation Levels of b-Catenin Signaling in Osteoblasts Define a Threshold for the Development of Myeloid Neoplasia of Variable Severity

Ioanna Mosialou, PhD, Alvaro Cuesta-Dominiguez, PhD, Govind Bhagat, MD, Ellin Berman, MD, Azra Raza, MD, Stavroula Kousteni, PhD

Blood (2017) 130 (Supplement 1): 2946.

https://doi.org/10.1182/blood.V130.Suppl_1.2946.2946

Published: 2017

Journal Articles

Role and Mechanisms of Rhoa G17V in the Pathogenesis of AITL

Jose R Cortes, PhD, Alberto Ambesi-Impiombato, MD PhD, Lucile Couronne, Christine S Kim, Zachary West, Laura Belver, PhD, Ana Carolina da Silva Almeida, PhD, Govind Bhagat, MD MBBS, Olivier A. Bernard, PhD, Adolfo A. Ferrando, MD PhD, Teresa Palomero, PhD

Blood (2016) 128 (22): 608.

https://doi.org/10.1182/blood.V128.22.608.608

Published: 2016

Journal Articles

VAV1 Activating Mutations and Translocations in Peripheral T-Cell Lymphomas

Blood (2016) 128 (22): 2741.

https://doi.org/10.1182/blood.V128.22.2741.2741

Published: 2016

Journal Articles

Targeting the Osteoblast in Myelodysplasia and Acute Myeloid Leukemia

Masahiro Marshall Nakagawa, Aruna Kode, Sanil J Manavalan, Govind Bhagat, MD, Julie Teruya-Feldstein, MD, Azra Raza, MD, Ellin Berman, MD, Stavroula Kousteni

Blood (2015) 126 (23): 2551.

https://doi.org/10.1182/blood.V126.23.2551.2551

Published: 2015

Journal Articles

Genomic and Targeted Mutational Analysis of T/NK-Cell Post-Transplant Lymphoproliferative Disorders Provides Insight into Disease Biology

Elizabeth Michelle Margolskee, MD, Vaidehi Jobanputra, Preti Jain, Jinli Chen, Odelia Nahum, Brynn Levy, Karthik A Ganapathi, MD PhD, Vundavalli Murty, Thomas Tousseyn, MDPhD, Bachir Alobeid, MD, Mahesh Manuskhani, MD, Govind Bhagat, MD MBBS

Blood (2015) 126 (23): 1475.

https://doi.org/10.1182/blood.V126.23.1475.1475

Published: 2015

Journal Articles

The Impact of Immunophenotypic Subtypes and Treatment Regimens on Patient Outcomes in Monomorphic Post-Transplant Lymphoproliferative Disorders (Diffuse Large B-Cell Lymphoma)

Dejan Radeski, MBBS,FRACP,FRCPA, Daniela Hoehn, MD PhD, Francesca Montanari, MD, Bachir Alobeid, MD, Yuan Zhang, MS MA, Jennifer E Amengual, MD, Ahmed Sawas, MD, Changchun Deng, MD PhD, Owen A. O'Connor, MD PhD, Govind Bhagat, MD

Blood (2014) 124 (21): 4449.

https://doi.org/10.1182/blood.V124.21.4449.4449

Published: 2014

Journal Articles

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma

Marco Fangazio, MD PhD, David Dominguez-Sola, MD PhD, Fabrizio Tabbò, MD, Davide Rossi, MD PhD, Julie Teruya-Feldstein, MD, Renzo Boldorini, MD, Gianluca Gaidano, MD PhD, Govind Bhagat, MD, Giorgio Inghirami, MD, Laura Pasqualucci, MD, Riccardo Dalla-Favera, MD

Blood (2014) 124 (21): 1692.

https://doi.org/10.1182/blood.V124.21.1692.1692

Published: 2014

Journal Articles

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Blood (2014) 124 (21): 1620.

https://doi.org/10.1182/blood.V124.21.1620.1620

Published: 2014

Journal Articles

Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Blood (2014) 124 (21): 143.

https://doi.org/10.1182/blood.V124.21.143.143

Published: 2014

Journal Articles

Foxo1 Expressed in Osteoblasts Promotes the Leukemogenic Properties of β-Catenin By Activating Notch Signaling

Aruna Kode, Ioanna Mosialou, Sanil J Manavalan, Julie Teruya Feldstein, Govind Bhagat, MD, Ellin Berman, MD, Stavroula Kousteni

Blood (2014) 124 (21): 2356.

https://doi.org/10.1182/blood.V124.21.2356.2356

Published: 2014

Journal Articles

Next-Generation High Throughput Sequencing Analysis In The Search Of Infectious Pathogens In Suspect Lymphoproliferations

Daniela Hoehn, MD, PhD, Jordan M. Schecter, MD, David Hirschberg, MD, Cadhla Firth, Craig R Street, Bachir Alobeid, MD, Ian W Lipkin, MD, Govind Bhagat, MD

Blood (2013) 122 (21): 3019.

https://doi.org/10.1182/blood.V122.21.3019.3019

Published: 2013

Journal Articles

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Jordan M. Schecter, MD, Daniela Hoehn, MD, PhD, Philip Imus, MD, Eleonora Alma, BS, Suzanne Lentzsch, MD, PhD, Bachir Alobeid, MD, Manuela Orjuela, MD, ScM, Owen A. O'Connor, MD, PhD, Govind Bhagat, MD

Blood (2013) 122 (21): 4333.

https://doi.org/10.1182/blood.V122.21.4333.4333

Published: 2013

NARROW

MYC and BCL2 mRNA Expression As Determined By NGS Predicts Survival in DLBCL in GCB but Not in ABC Subgroup

Cell of Origin and Treatment Impact on the Outcome of Monomorphic Post-Transplant Lymphoproliferative Disorder-Diffuse Large B-Cell Lymphoma Subtype

Cell of Origin Classification of DLBCL Using Targeted NGS Expression Profiling and Deep Learning

Whole Exome and Transcriptome Sequencing in 1042 Cases Reveals Distinct Clinically Relevant Genetic Subgroups of Follicular Lymphoma

Novel Drugs and Clinical Trial-Based Treatments Prolong Survival of Peripheral T-Cell Lymphomas (PTCL) Patients: Single Institution Retrospective Analysis

Higher Stability of Mutant mRNA As Compared to Wild-Type mRNA in Diffuse Large B-Cell Lymphoma

Clinical Significance of PD-1 and PD-L1 Expression and Ongoing Interaction in the Tumor Microenvironment in Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Molecular Characterization of Post-Transplant Plasmablastic Lymphomas Implicates RAS , TP53 , and NOTCH Mutations and MYC Deregulation in Disease Pathogenesis

Activation Levels of b-Catenin Signaling in Osteoblasts Define a Threshold for the Development of Myeloid Neoplasia of Variable Severity

Role and Mechanisms of Rhoa G17V in the Pathogenesis of AITL

VAV1 Activating Mutations and Translocations in Peripheral T-Cell Lymphomas

Targeting the Osteoblast in Myelodysplasia and Acute Myeloid Leukemia

Genomic and Targeted Mutational Analysis of T/NK-Cell Post-Transplant Lymphoproliferative Disorders Provides Insight into Disease Biology

The Impact of Immunophenotypic Subtypes and Treatment Regimens on Patient Outcomes in Monomorphic Post-Transplant Lymphoproliferative Disorders (Diffuse Large B-Cell Lymphoma)

Genetic Mechanisms of Immune Escape in Diffuse Large B Cell Lymphoma

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Foxo1 Expressed in Osteoblasts Promotes the Leukemogenic Properties of β-Catenin By Activating Notch Signaling

Next-Generation High Throughput Sequencing Analysis In The Search Of Infectious Pathogens In Suspect Lymphoproliferations

Pathologic and Clinical Features Of CD30+ Post-Transplant Lymphoproliferative Disorders: A Large Retrospective Single Institutional Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only